Our pathway profiling services offer unmatched early-on knowledge of disease-related cellular mechanisms to revitalize drug development for genetically complex diseases. About us Our vision at Systasy as a start-up biotechnology company has been to develop novel approaches in the field of personalized medicine for almost ten years. Our portfolio consists of a broad range of innovative technologies to revolutionize the process of tailored drug development. The key buzzwords here are "molecular barcoding" and "next generation sequencing", or NGS for short. These strategies allow a large number of cellular processes to be mapped simultaneously. Therapeutic possibilities arise from the application of rapidly developing stem cell technology, i.e. the production of stem cells also from patient samples and their differentiation primarily into neuronal cell types. Our culture We are seeking attentive people who work solution driven and values a healthy team-spirited work environment. In our team everybody is committed and works independently towards our goals. We are used to flat hierarchies, which is why we constantly want to improve ourselves and our processes.